Anderson J P, Hughes D C, Stevens L M. "一种阿法替尼杂质33的合成方法" [P]. US Patent, US 11281588 B2, 2015-02-28.
发明人孙丽萍,郭海燕,胡光. "Method for the Synthesis of Afatinib Impurity 33" [P]. 中国发明专利, 专利号 CN 115132683 B, 授权公告日 2023-10-02.
Hughes D C, Thompson G K, Brown S R. "A Process for Preparing High-Purity Afatinib Impurity 33" [P]. US Patent, US 11122765 B2, 2021-08-28.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 阿法替尼杂质33 in Pharmaceutical Formulations". J. Chromatogr. A, 2011, 127, 7004-7022.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿法替尼杂质33 as an Impurity". J. Sep. Sci., 2013, 143, 7835-7847.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Afatinib Impurity 33 Using HRMS and NMR". J. Agric. Food Chem., 2025, 2418, 3722-3730.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 阿法替尼杂质33 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2010, 1121, 3296-3315.